Nanodropper adaptor

DEVICE2 trials

Sponsors

Nanodropper, Inc., University of Washington

Conditions

GlaucomaGlaucoma and Ocular HypertensionGlaucoma, Open-AngleGlaucoma, Primary Open AngleOcular Hypertension

Unknown Phase

Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients

CompletedNCT05181046

Nanodropper, Inc.Glaucoma, Glaucoma and Ocular Hypertension, Glaucoma, Open-Angle +2

Start: 2021-11-06End: 2022-12-19Updated: 2023-01-18

Use of Nanodropper vs. Standard Eyedropper in Patients With Glaucoma and Ocular Hypertension

University of WashingtonGlaucoma, Open-Angle, Ocular Hypertension

Start: 2022-02-28End: 2025-06-30Target: 150Updated: 2022-03-14